Side by side to combat MRSA
With complementary portfolios, GlaxoSmithKline (GSK) and B. Braun have been working together since mid- May to develop a complete one-stop system for the decontamination of MRSA patients
GSK’s Turixin nasal ointment containing the active substance mupirocin has been an established antibiotic treatment for years and is recommended by the Robert Koch Institute to decontaminate nasal MRSA colonisation*. B. Braun’s Prontoderm range, containing polyhexanide, includes a shampoo for the hair; moist cleansing wipes, a mouth rinse solution and a whole body was product – either ready for use or as a concentrate, and as a shower gel. Used together, both products enable comprehensive elimination of MRSA bacteria.
In its future advice booklets and specialist documentation B. Braun will recommend the nasal ointment with mupirocin for decontamination of nasal MRSA. Further joint activities, such as networking events, participation in trade shows, an MRSA kit and a film on MRSA are also planned. Actual sales of Turixin will continue directly through GSK.
* N. Wischnewski, M. Mielke 2007. Overview of current eradication strategies for methicillin-resistant Staphylococcus aureus (MRSA) from various countries. Hyg Med 2007; 32 [10], 389
10.07.2012
